Improving cancer patients’ health through our unwavering commitment to discover, develop and deliver life-changing oncology drugs
About Nerviano Medical Sciences
Nerviano Medical Sciences S.r.l. (NMS) specializes in the discovery and clinical development of New Chemical Entities (NCEs) for oncology, including Small Molecules and Antibody Drug Conjugates (ADCs). We focus on innovative drug targets and mechanisms of action to deliver first- and best-in-class personalized cancer treatments.
Our Science
Driven by Expertise, Focused on Innovative Impact
At NMS, our scientific platforms form the foundation of our mission to deliver innovative cancer treatments to patients. Leveraging our deep expertise in Small Molecules and Antibody-Drug Conjugates (ADCs), we drive novel therapies from discovery to clinical development, moving from the bench to the bedside. Our proven track record showcases our ability to develop first- and best-in-class molecules, bringing hope to patients in need.
